LEPR and obesity due to melanocortin 4 receptor deficiency: This seemingly counterintuitive observation is partially supported by data suggesting complex associations of obesity/adiposity, LEP/LEPR’s activation of various signaling pathways, and breast cancer progression, which is further complicated by ER expression [46, 47].